The genetic testing industry is progressing rapidly. In particular, the demand of patients with tumors for diagnosis, treatment, and testing drives genetic testing to develop further. Simultaneously, the potential risks of genetic testing cause severe challenges to regulatory departments. In China, a targeted, clear, and unified management model remains absent.
Keywords: genetic testing; regulation; supervision.
Copyright © 2020 Elsevier Ltd. All rights reserved.